New Delhi, March 30 -- The Delhi High Court has allowed Dr. Reddy's Laboratories to supply any remaining stock of its semaglutide drug Olymviq to government hospitals after the expiry of a 30-day stoc... Read More
New Delhi, March 27 -- New Delhi, Mumbai : The Delhi High Court on Friday refused to allow the destruction of Dr Reddy's Laboratories Ltd's inventory of its generic semaglutide drug, Olymviq, while ... Read More
New Delhi, March 11 -- The Supreme Court on Wednesday allowed India's first court-approved "passive euthanasia", permitting the withdrawal of life-sustaining treatment for Harish Rana, a 32-year-old m... Read More
New Delhi, Feb. 25 -- India's generic drugmakers will no longer automatically face damages claims linked to expired patents after the Delhi High Court ruled that even a patent that has completed its 2... Read More
New Delhi, Feb. 8 -- Piramal Pharma Ltd has moved the Supreme Court against a Gujarat Pollution Control Board order directing the immediate closure of its Dahej manufacturing unit over alleged environ... Read More
New Delhi, Jan. 19 -- The Delhi High Court's division bench on Monday reserved its verdict on Danish drugmaker Novo Nordisk's appeal against a single-judge order that allowed Dr Reddy's Laboratories t... Read More
New Delhi, Jan. 12 -- In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anti-cancer drug nivolumab i... Read More
New Delhi, Jan. 12 -- In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anti-cancer drug nivolumab i... Read More
New Delhi, Jan. 6 -- New Delhi, Mumbai : Hyderabad-based Natco Pharma Ltd has filed a patent revocation petition before the Delhi high court against Danish drugmaker Novo Nordisk, which sells weight... Read More